Ascendis pharma a/s (ASND)
Income statement / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Other comprehensive income / (loss)
Items that may be reclassified subsequently to profit or loss:
Number of shares used for calculation (basic and diluted)

41,888

41,650

38,699

36,966

32,607

32,502

32,428

Number of shares used for calculation (diluted)

-

41,650

-

-

-

32,502

-